Cellectis S.A. Reports Results from Shareholders’ General Meeting Held on May 17, 2016
Published on May 19, 2016
New York, May 19, 2016 – Cellectis S.A. Shareholders’ General Meeting (Alternext: ALCLS - Nasdaq: CLLS) was held on Tuesday, May 17, 2016 in Paris, at its head office.
At the meeting, during which more than 62% of voting rights were exercised, 21 of 22 resolutions were adopted.
Each of the 21 resolutions, adopted in accordance with the recommendation of the board of directors, received more than 75% votes in favor. Resolution No. 22, regarding a capital increase reserved for members of a company savings plan, was rejected in accordance with the recommendation of the board of directors.
The resolutions adopted by Cellectis' shareholders included:
• The approval of the financial statements for the financial year ended December 31, 2015
• The approval of specified related-party agreements
• The reappointment of Mr. Mathieu Simon to the board of directors
• Authorization of a share repurchase plan and authorization of the retirement of the shares acquired through it
• Delegations of authority given to the board of directors to increase share capital up to specified limits
• Resolutions authorizing Cellectis to grant its executive officers, employees, consultants and directors equity compensation up to specified limits
The full results of the vote can be examined on the company’s website (www.cellectis.com).